Emcure Financial Statements From 2010 to 2024
| EMCURE Stock | 1,421 33.45 2.41% |
Profit Margin 0.074 | Market Capitalization 271 B | Enterprise Value Revenue 4.6575 | Revenue 69.2 B | Earnings Share 26.38 |
Check Emcure Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Emcure Pharmaceuticals' main balance sheet or income statement drivers, such as , as well as many indicators such as . Emcure financial statements analysis is a perfect complement when working with Emcure Pharmaceuticals Valuation or Volatility modules.
Emcure |
Emcure Pharmaceuticals Company Shares Owned By Insiders Analysis
Emcure Pharmaceuticals' Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Emcure Pharmaceuticals Shares Owned By Insiders | 86.77 % |
Most of Emcure Pharmaceuticals' fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Emcure Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 86% of Emcure Pharmaceuticals are shares owned by insiders. This is much higher than that of the Healthcare sector and notably higher than that of the Drug Manufacturers - Specialty & Generic industry. The shares owned by insiders for all India stocks is notably lower than that of the firm.
Emcure Pharmaceuticals Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Emcure Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Emcure Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Emcure Pharmaceuticals competition to find correlations between indicators driving Emcure Pharmaceuticals's intrinsic value. More Info.Emcure Pharmaceuticals is rated below average in profit margin category among its peers. It also is rated below average in operating margin category among its peers reporting about 1.81 of Operating Margin per Profit Margin. Comparative valuation analysis is a catch-all model that can be used if you cannot value Emcure Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Emcure Pharmaceuticals' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Emcure Pharmaceuticals Financial Statements
Emcure Pharmaceuticals stakeholders use historical fundamental indicators, such as Emcure Pharmaceuticals' revenue or net income, to determine how well the company is positioned to perform in the future. Although Emcure Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. For example, changes in Emcure Pharmaceuticals' assets and liabilities are reflected in the revenues and expenses on Emcure Pharmaceuticals' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Emcure Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Emcure Pharmaceuticals is entity of India. It is traded as Stock on NSE exchange.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Emcure Stock
Emcure Pharmaceuticals financial ratios help investors to determine whether Emcure Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Emcure with respect to the benefits of owning Emcure Pharmaceuticals security.